[Clostridium difficile infection].
Grünewald
T
T
Klinik für Infektiologie, Tropenmedizin und Nephrologie, Städtisches Klinikum Sankt Georg, Leipzig.
Kist
M
M
Mutters
R
R
Ruf
B R
BR
Kern
W V
WV
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D001431:Bacteriological Techniques; D002981:Clindamycin / Q000009:adverse effects; D016360:Clostridioides difficile; D003082:Colectomy; D003113:Colonoscopy; D003430:Cross-Sectional Studies; D020345:Enterocolitis, Necrotizing / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D024841:Fluoroquinolones / Q000009:adverse effects; D006801:Humans; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D015994:Incidence; D008795:Metronidazole / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D019936:Probiotics / Q000627:therapeutic use; D011379:Prognosis; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D008795:Metronidazole; D002981:Clindamycin; D014640:Vancomycin